2-es típusú cukorbetegség: vizsgálatok itt: Argentína

21 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  Where

  Buenos Aires, Ciudad Autonoma Buenos Aires, Mar del Plata

  Életkor

  18 év and over

  People

  2000 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07351045 · EU 2025-523104-71-00
• 3. fázisTaking people
  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  Where

  Buenos Aires, Ciudad Autonoma Buenos Aires, Mar del Plata

  Életkor

  18 év and over

  People

  1600 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07351058 · EU 2025-523106-32-00
• 3. fázisTaking people
  A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  Where

  Buenos Aires, CABA, Ciudad de Buenos Aires, Ramos Mejía, Rosario, San Nicolás

  Életkor

  18 év and over

  People

  500 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07776509 · EU 2025-523295-23-00
• 2. fázisTaking people
  A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  Where

  Buenos Aires, Rosario, Santa Fe, Santa Rosa

  Életkor

  18 év and over

  People

  120 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07783802
• 3. fázisNot yet taking people in Argentína
  A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

  Where

  Bahía Blanca, Buenos Aires, Ciudad de Buenos Aires, Córdoba, Del Viso, Godoy Cruz, Granadero Baigorria, Junín, Mar del Plata, Mendoza, Rosario, SAN M. de Tucuman, Santiago del Estero

  Életkor

  18 év and over

  People

  2115 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07881432 · EU 2026-526047-34-00
• 2. fázisNot yet taking people in Argentína
  A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes

  Where

  Buenos Aires, Rosario

  Életkor

  18 év to 75 év

  People

  460 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07890376
• 3. fázisNot yet taking people in Argentína
  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

  Where

  Buenos Aires, CABA, Córdoba, Granadero Baigorria, Lanus, Mar del Plata, Ramos Mejía, Rosario, San Fernando, San Nicolás, Santa Fe

  Életkor

  45 év to 64 év

  People

  3000 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07900633 · EU 2026-525919-14-00
• 3. fázisTaking people
  A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  Where

  Buenos Aires, CABA, Ciudad de Buenos Aires, Mar del Plata, Rosario, San Nicolás, San Vicente

  Életkor

  18 év and over

  People

  2000 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07662109 · EU 2025-523941-81-00
• 3. fázisTaking people
  A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  Where

  Buenos Aires, Ciudad de Buenos Aires, Mendoza, Ramos Mejía, Rosario, San Nicolás

  Életkor

  18 év and over

  People

  2500 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07784725 · EU 2025-523379-41-00
• 3. fázisTaking people
  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  Where

  Bahía Blanca, Buenos Aires, CABA, Ciudad Autonoma Buenos Aires, Ciudad Autonoma de Bs As, Córdoba, Godoy Cruz, Granadero Baigorria, Mar del Plata, Parque Velez Sarsfield, Río Cuarto, Rosario, Santa Fe, Villa Luro

  Életkor

  18 év and over

  People

  11 800 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07064473 · EU 2025-521188-11-00
• 3. fázisTaking people
  A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  Where

  Buenos Aires, CABA, Ciudad de Buenos Aires, Mendoza, Ramos Mejía, Rosario, San Nicolás

  Életkor

  18 év and over

  People

  1500 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07784270
• 3. fázisTaking people
  A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  Where

  Buenos Aires, CABA, Ciudad de Buenos Aires, Rosario, San Nicolás, San Vicente

  Életkor

  18 év and over

  People

  1200 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07662213 · EU 2025-523933-24-00
• 3. fázisTaking people
  A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  Where

  Capital Federal, City of Buenos Aires, Godoy Cruz, San Miguel de Tucumán

  Életkor

  10 év to 18 év

  People

  80 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT07282613
• 3. fázisTaking people
  A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

  Where

  Buenos Aires, CABA, Capital Federal, Granadero Baigorria, Lanus, Rosario, San Nicolás, San Vicente

  Életkor

  18 év and over

  People

  4500 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07667803
• 3. fázisTaking people
  A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  Where

  Buenos Aires, CABA, Capital Federal, Ciudad Autónoma de Buenos Aires, Ciudad de Buenos Aires, San Miguel de Tucumán, Santa Fe, Santiago del Estero

  Életkor

  18 év and over

  People

  2500 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT07564414 · EU 2025-522488-14-00
• 3. fázisTaking people
  A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  Where

  Buenos Aires, Córdoba, Rosario, San Miguel de Tucumán

  Életkor

  18 év and over

  People

  1980 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07321886 · EU 2025-523657-34-00
• 3. fázisTaking people
  AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  Where

  Bahía Blanca, Buenos Aires, CABA, Ciudad Autonoma de Buenos Aires, Ciudad Autónoma de Buenos Aires, Córdoba, Godoy Cruz, Mar del Plata, Rosario, San Juan, San Miguel de Tucumán, San Rafael

  Életkor

  45 év and over

  People

  1778 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT07797335
• 3. fázisTaking people
  A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

  Where

  Buenos Aires, CABA, Ciudad de Buenos Aires, Mar del Plata, San Nicolás, Santa Fe, San Vicente

  Életkor

  18 év and over

  People

  800 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07662044 · EU 2025-523936-37-00
• 3. fázisTaking people
  A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  Where

  Buenos Aires, Mar del Plata, Rosario, San Miguel de Tucumán, San Nicolás

  Életkor

  10 év to 17 év

  People

  55 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT06739122
• No phaseTaking people
  Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin

  Where

  Buenos Aires

  Életkor

  18 év and over

  People

  145

  Run by

  Hospital Italiano de Buenos Aires

  See details and how to joinNCT07621419
• 2. fázisTaking people
  A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

  Where

  City of Buenos Aires, Corrientes, Lanús Este, Mar del Plata

  Életkor

  18 év and over

  People

  465 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06717698 · EU 2024-510846-15-00